Published in Arterioscler Thromb Vasc Biol on October 01, 1997
Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res (2008) 2.13
Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. CMAJ (2005) 1.90
Exposure to traffic pollution and increased risk of rheumatoid arthritis. Environ Health Perspect (2009) 1.70
Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A (2005) 1.62
Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med (2005) 1.55
Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther (2010) 1.46
Environmental and gene-environment interactions and risk of rheumatoid arthritis. Rheum Dis Clin North Am (2012) 1.26
Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood. Clin Diagn Lab Immunol (2003) 1.21
Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med (2007) 1.20
Relation of smoking status to a panel of inflammatory markers: the framingham offspring. Atherosclerosis (2008) 1.20
Cardiovascular and lifestyle risk factors in lumbar radicular pain or clinically defined sciatica: a systematic review. Eur Spine J (2007) 1.13
Epidemiology, heritability, and genetic linkage of C-reactive protein in African Americans (from the Jackson Heart Study). Am J Cardiol (2008) 1.10
Mortality rates in smokers and nonsmokers in the presence or absence of coronary artery calcification. JACC Cardiovasc Imaging (2012) 1.09
Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study. Atherosclerosis (2008) 1.08
Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture. Mediators Inflamm (2012) 1.08
Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci (2012) 1.04
Common variants in the CRP gene in relation to longevity and cause-specific mortality in older adults: the Cardiovascular Health Study. Atherosclerosis (2007) 1.01
Relationship of cigarette smoking with inflammation and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol (2015) 1.00
Chronic idiopathic neutrophilia in a smoker, relieved after smoking cessation with the use of electronic cigarette: a case report. Clin Med Insights Case Rep (2013) 0.98
Levels of acute phase proteins remain stable after ischemic stroke. BMC Neurol (2006) 0.95
Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients. Atherosclerosis (2013) 0.94
Increased leukocyte rho kinase (ROCK) activity and endothelial dysfunction in cigarette smokers. Hypertens Res (2010) 0.92
Factors associated with inflammation markers, a cross-sectional analysis. Cytokine (2011) 0.89
Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis. Neurology (2009) 0.89
Retrospective analysis of the relationship between decline in FEV(1) and abdominal circumference in male smokers: the Takahata study. Int J Med Sci (2012) 0.88
Cigarette smoke modulates vascular smooth muscle phenotype: implications for carotid and cerebrovascular disease. PLoS One (2013) 0.88
Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study. Breast Cancer Res Treat (2011) 0.87
Socioeconomic indices as independent correlates of C-reactive protein in the National Longitudinal Study of Adolescent Health. Psychosom Med (2013) 0.86
Cigarette Smoking does not Induce Plasma or Pulmonary Oxidative Stress after Moderate-intensity Exercise. J Phys Ther Sci (2014) 0.86
Cigarette smoking increases the risk of root canal treatment. J Dent Res (2006) 0.83
Microbiota and chronic inflammatory arthritis: an interwoven link. J Transl Med (2016) 0.83
Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups. Schizophr Res (2015) 0.83
An Evaluation of the Clinical Evidence on the Role of Inflammation and Oxidative Stress in Smoking-Mediated Cardiovascular Disease. Biomark Insights (2008) 0.83
The relationship between deprivation, tumour stage and the systemic inflammatory response in patients with primary operable breast cancer. Br J Cancer (2004) 0.82
Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life. Open Cardiovasc Med J (2010) 0.82
Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans. Hum Genet (2014) 0.82
Evaluation of clinical variables associated with increased carotid intima-media thickness in middle-aged hypertensive women. Int J Hypertens (2012) 0.82
Sexual orientation and gender differences in markers of inflammation and immune functioning. Ann Behav Med (2014) 0.81
The association between self-reported symptoms of recent airway infection and CRP values in a general population. Inflammation (2012) 0.80
Influence of hypertension, obesity and nicotine abuse on quantitative and qualitative changes in acute-phase proteins in patients with essential hypertension. Med Sci Monit (2012) 0.79
Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases. Mediators Inflamm (2012) 0.78
Long-term smoking causes more advanced coronary endothelial dysfunction in middle-aged smokers compared to young smokers. Eur J Nucl Med Mol Imaging (2010) 0.78
The elusive link between high sensitivity C-reactive protein and carotid subclinical atherosclerosis in coronary artery bypass grafting candidates: a cross-sectional study. Cardiovasc Ultrasound (2008) 0.78
Association between Hypertension and the Prevalence of Low Back Pain and Osteoarthritis in Koreans: A Cross-Sectional Study. PLoS One (2015) 0.78
Acute Immune-Inflammatory Responses to a Single Bout of Aerobic Exercise in Smokers; The Effect of Smoking History and Status. Front Immunol (2015) 0.78
Effects of smoking cessation on serum leptin and adiponectin levels. Tob Induc Dis (2015) 0.77
Factors associated with ischemic stroke on therapeutic anticoagulation in patients with nonvalvular atrial fibrillation. Yonsei Med J (2015) 0.77
Associations between Inflammatory Markers and Subclinical Atherosclerosis in Middle-aged White, Japanese-American and Japanese Men: The ERA-JUMP Study. J Atheroscler Thromb (2014) 0.77
Body mass index and C-reactive protein in the healthy Korean aged men. J Korean Med Sci (2006) 0.77
The impacts of C-reactive protein and atrial fibrillation on carotid atherosclerosis and ischemic stroke in patients with suspected ischemic cerebrovascular disease: a single-center retrospective observational cohort study. Korean Circ J (2013) 0.77
Inverse Correlation between Serum C-Reactive Protein and Magnesium Levels in Smokers and Nonsmokers. N Am J Med Sci (2015) 0.77
Serum IGF-I and C-reactive protein in healthy black and white young men: the CARDIA male hormone study. Growth Horm IGF Res (2009) 0.77
The relationship between serum levels of hs-CRP and coronary lesion severity. Clujul Med (2016) 0.76
Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients. Mediators Inflamm (2010) 0.76
Inflammatory markers and intimal media thickness in diabetics with negative myocardial perfusion scan. J Clin Med Res (2009) 0.75
Soluble CD40 ligand levels in otherwise healthy subjects with impaired fasting glucose. Mediators Inflamm (2006) 0.75
Gender and the active smoking and high-sensitivity C-reactive protein relation in late adolescence. J Lipid Res (2014) 0.75
Functional, Cellular, and Molecular Remodeling of the Heart under Influence of Oxidative Cigarette Tobacco Smoke. Oxid Med Cell Longev (2017) 0.75
The association between cigarette smoking and inflammation: The Genetic Epidemiology Network of Arteriopathy (GENOA) study. PLoS One (2017) 0.75
Unhealthy smokers: scopes for prophylactic intervention and clinical treatment. BMC Neurosci (2017) 0.75
The Cardiovascular Health Study: design and rationale. Ann Epidemiol (1991) 27.24
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol (1995) 10.26
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation (1995) 9.13
Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics (1998) 8.48
Incidence of and risk factors for atrial fibrillation in older adults. Circulation (1997) 8.18
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem (1995) 7.73
Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet (1986) 7.35
Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol (1995) 7.28
DISTRIBUTION OF ASCORBIC ACID IN THE BLOOD AND ITS NUTRITIONAL SIGNIFICANCE. J Clin Invest (1940) 6.38
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol (1997) 6.10
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet (2000) 5.42
The messenger under attack -- intimidation of researchers by special-interest groups. N Engl J Med (1997) 5.14
Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care (1990) 4.49
Community-level comparisons between the grocery store environment and individual dietary practices. Prev Med (1991) 4.45
Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke (1991) 4.21
Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol (2000) 4.16
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol (1994) 4.08
Menopause and risk factors for coronary heart disease. N Engl J Med (1989) 3.84
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes (1984) 3.66
Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet (1998) 3.61
Are drugs within a class interchangeable? Lancet (1999) 3.58
JNC VI: timing is everything. Lancet (1997) 3.48
Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol (1999) 3.36
The association of skin color with blood pressure in US blacks with low socioeconomic status. JAMA (1991) 3.29
Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. Am Heart J (1984) 3.25
Time to act on drug safety. JAMA (1998) 3.22
Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol (1996) 3.18
Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes (1990) 3.07
Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med (1994) 3.04
The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adults. J Am Geriatr Soc (1997) 2.98
Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology (2002) 2.98
Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group. Ann Intern Med (1992) 2.96
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation (2000) 2.94
Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol (2001) 2.93
Predicting risk of dementia in older adults: The late-life dementia risk index. Neurology (2009) 2.92
Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation (1998) 2.83
British guidelines on managing hypertension. Provide evidence, progress, and an occasional missed opportunity. BMJ (1999) 2.83
Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol (1997) 2.76
Diabetes mellitus, race, and socioeconomic status. A population-based study. Ann Epidemiol (1996) 2.71
Subclinical disease as an independent risk factor for cardiovascular disease. Circulation (1995) 2.71
Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation (2000) 2.71
Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol (2001) 2.68
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA (1998) 2.64
A randomized walking trial in postmenopausal women: effects on physical activity and health 10 years later. Arch Intern Med (1998) 2.62
Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA (1996) 2.53
The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes (2001) 2.47
Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group. Ann Intern Med (1999) 2.43
Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study. Neurology (2010) 2.41
Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology (2001) 2.41
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study. J Thromb Haemost (2007) 2.40
Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis (2001) 2.40
Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst (1999) 2.40
Educational attainment and behavioral and biologic risk factors for coronary heart disease in middle-aged women. Am J Epidemiol (1989) 2.39
Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization. J Immunol (1979) 2.38
Differences in sociodemographic, health status, and lifestyle characteristics among American Indians by telephone coverage. Prev Med (1994) 2.37
Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA (1993) 2.28
The association between cholesterol and death from injury. Ann Intern Med (1994) 2.26
Family history as a risk factor for primary cardiac arrest. Circulation (1998) 2.25
Antihypertensive drug therapies and the risk of ischemic stroke. Arch Intern Med (2001) 2.24
The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol (1989) 2.23
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care (2000) 2.22
Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study. JAMA (1992) 2.21
Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum (1999) 2.21
Treatment of hypertensive patients with diabetes. Lancet (1998) 2.16
Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood (1997) 2.15
Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol (1999) 2.15
Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis. J Thromb Haemost (2013) 2.13
Nocturnal enuresis in community-dwelling older adults. J Am Geriatr Soc (1996) 2.11
Cholesterol-lowering intervention program. Effect of the step I diet in community office practices. Arch Intern Med (1996) 2.11
Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA (1993) 2.06
The unnecessary controversy. Eur Heart J (1996) 2.05
Trends in pharmacologic management of hypertension in the United States. Arch Intern Med (1995) 2.04
Prospective study of the determinants of age at menopause. Am J Epidemiol (1997) 2.02
Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study. Arch Intern Med (2001) 2.01
Effects of passive smoking in the Multiple Risk Factor Intervention Trial. Am J Epidemiol (1987) 1.93
Weight gain at the time of menopause. Arch Intern Med (1991) 1.89
Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group. Am J Cardiol (1992) 1.89
NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type. Neurology (2007) 1.88
Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev (1997) 1.88
The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Hum Hypertens (2010) 1.86
Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. JAMA (1987) 1.86